- In this section:
- TruCytes product flyer
TruCytes™ from Slingshot Biosciences are high performing synthetic cells with key biomarkers that can be customised to match rare haematology disease, even pooly expressed markers. Customisable to any cell population, TruCytes match the optical, fluorescence, and biochemical features of cells with exceptional stability compared to biologically-derived cellular controls.
Benefits of using TruCytes
• Accurate antigen density of match cell types
• Greater reliability and accuracy than traditional controls
• Cost-efficient and batch-to-batch consistency
• Ideal for TBNK assays
• Fully customisable biomarker expression to mimic even the rarest diseases
Left: Whole Blood. Right: TruCytes TBNK. TryCytes TBNK synthetic cellular controls match the biochemical profile and optical properties of any target cell populations, eliminating the drawbacks that traditionally come with using bio-based cellular controls
TruCytes individual positive populations
Material available for download
TruCytes product flyer
TruCytes is a registered trademark of Slingshot Bioscience, Inc.
Products
Note: product availability depends on country - see product detail page.
Details | Cat number & supplier | Size | Price |
TruCytes™ TBNK SSB-08-A · Slingshot Biosciences | SSB-08-A Slingshot Biosciences |
250000 cells per vial |
£87.00
250000 cells per vial
view
|
TruCytesTM T-Cell, CD4+ Cell mimics SSB-09-A · Slingshot Biosciences | SSB-09-A Slingshot Biosciences |
250000 cells per vial |
£87.00
250000 cells per vial
view
|
TruCytesTM T-Cell, CD8+ Cell mimics SSB-10-A · Slingshot Biosciences | SSB-10-A Slingshot Biosciences |
250000 cells per vial |
£87.00
250000 cells per vial
view
|
TruCytesTM B-Cell, CD19+ Cell mimics SSB-11-A · Slingshot Biosciences | SSB-11-A Slingshot Biosciences |
250000 cells per vial |
£87.00
250000 cells per vial
view
|
TruCytesTM NK-Cell, CD56/CD16+ Cell mimics SSB-12-A · Slingshot Biosciences | SSB-12-A Slingshot Biosciences |
250000 cells per vial |
£87.00
250000 cells per vial
view
|